Quanta Fluid Solutions Ltd, an Alcester, UK-based developer of advanced haemodialysis systems, received an Invention for Innovation (i4i) award worth £1.85 million from the National Institute for Health Research (NIHR) – the research arm of the NHS.
The funds will be used to develop a new product concept for nocturnal haemodialysis leveraging the company’s knowledge in the development of its CE marked, portable, cartridge-based haemodialysis system, SC+.
Led by John E. Milad, Chief Executive Officer, Quanta has recently obtained CE Mark for its flagship product SC+, which is a portable, compact cartridge-based haemodialysis system designed to offer flexibility whilst facilitating self-care and supporting dialysis patients across the entire continuum of care.
Quanta is collaborating on the new project with Professor William Zimmerman of the Department of Chemical and Biological Engineering at Sheffield University and Europlaz Technologies Ltd, a medical device manufacturer in the UK.
Professor Zimmerman’s research group will be contributing towards advanced multi-physics modelling of haemodialysis and Europlaz will be involved in the further development of technologies to be incorporated into the disposable cartridges, which are a core element of Quanta’s system design and proprietary technology platform.
Founded in 2008 as a spin out from the FTSE 100 engineering company IMI plc, Quanta has received funding from venture capital investors NBGI Ventures, Wellington Partners, Seroba Kernel and b-to-v Partners, ALIAD, Seventure Partners and Kuwait Life Sciences Company.